Rate My Professor Andrew Boyle

Returning to Australia, Boyle established his research program at the Hunter Medical Research Institute and practices as an interventional cardiologist at John Hunter Hospital, specializing in coronary stenting, transcatheter aortic valve implantation, and acute coronary syndromes. His research encompasses basic science, translational, and clinical studies on left ventricular remodeling, molecular mechanisms of cardiac fibrosis, apoptosis, stem cell function, heart failure, and systems-of-care improvements in rural settings. He has secured over $13 million in competitive funding from sources including the National Health and Medical Research Council, National Heart Foundation of Australia, and Hunter Medical Research Institute, notably leading a 2022 randomized controlled trial on patient well-being post-acute decompensated heart failure ($964,531) and cardiac fibrosis projects funded by Australian Rotary Health. Boyle has authored over 150 peer-reviewed publications, including highly cited works such as "Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation" (Circulation Research, 2010; 921 citations), "The aging heart and post-infarction left ventricular remodeling" (Journal of the American College of Cardiology, 2011; 285 citations), and "The processes and mechanisms of cardiac and pulmonary fibrosis" (Frontiers in Physiology, 2017; 268 citations). A Fellow of the American College of Cardiology (2008), American Heart Association (2009), and Society for Cardiac Angiography and Intervention (2010), he co-directs the Heart and Stroke Research Program at HMRI, chairs the Clinical Trials Subcommittee of the Hunter New England Human Research Ethics Committee, and leads the Executive Committee of the NSW Cardiovascular Research Network. Boyle supervises PhD students and junior doctors, contributing to advancements in rural acute coronary syndrome management.